TUBULAR LIPIDOSIS - EPIPHENOMENON OR PATHOGENETIC LESION IN HUMAN RENAL-DISEASE

被引:41
作者
ONG, ACM [1 ]
MOORHEAD, JF [1 ]
机构
[1] ROYAL FREE HOSP,DEPT NEPHROL & TRANSPLANTAT,LONDON,ENGLAND
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ki.1994.100
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Tubular lipidosis is a commonly observed histological lesion in proteinuric renal diseases. We have studied the interaction between native and modified human lipoproteins and human renal proximal tubular cells to investigate whether lipoproteins could be injurious to tubular cells in culture. Human renal proximal tubular cells were cultured and characterized by established methods. Preliminary studies showed that these cells could take up and degrade normal human lipoproteins by high affinity (HDL) and low affinity (LDL) pathways. In subconfluent culture, native lipoproteins, that is, LDL, HDL(2) and HDL(3), had markedly different effects on cell growth as measured by H-3-thymidine uptake and total cell protein as compared to modified lipoproteins such as minimally modified and oxidized LDL. In addition, we found that renal tubular cells could oxidize native LDL in the presence of copper largely by a superoxide-mediated mechanism. Finally, cellular accumulation of lipid was demonstrated in vitro by incubating cultured cells with varying lipoprotein concentrations for up to 48 hours. Notably, cell detachment was observed only with high concentrations of modified LDL especially with minimally modified LDL. We speculate that uptake and oxidation of filtered LDL by tubular cells may lead to tubular injury in nephrotic states.
引用
收藏
页码:753 / 762
页数:10
相关论文
共 61 条
[51]   INVITRO AND INVIVO INTERLEUKIN-8 PRODUCTION IN HUMAN RENAL CORTICAL EPITHELIA [J].
SCHMOUDER, RL ;
STRIETER, RM ;
WIGGINS, RC ;
CHENSUE, SW ;
KUNKEL, SL .
KIDNEY INTERNATIONAL, 1992, 41 (01) :191-198
[52]  
SEGAL P, 1979, J LIPID RES, V20, P784
[53]   SERUM AND URINARY LIPOPROTEINS IN THE HUMAN NEPHROTIC SYNDROME - EVIDENCE FOR RENAL CATABOLISM OF LIPOPROTEINS [J].
SHORE, VG ;
FORTE, T ;
LICHT, H ;
LEWIS, SB .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (03) :258-268
[54]   ROLE OF OXIDATIVELY MODIFIED LDL IN ATHEROSCLEROSIS [J].
STEINBRECHER, UP ;
ZHANG, HF ;
LOUGHEED, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1990, 9 (02) :155-168
[55]   MODIFICATION OF LOW-DENSITY LIPOPROTEIN BY ENDOTHELIAL-CELLS INVOLVES LIPID-PEROXIDATION AND DEGRADATION OF LOW-DENSITY LIPOPROTEIN PHOSPHOLIPIDS [J].
STEINBRECHER, UP ;
PARTHASARATHY, S ;
LEAKE, DS ;
WITZTUM, JL ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (12) :3883-3887
[56]  
Thomas Mark E., 1992, Journal of the American Society of Nephrology, V3, P752
[57]   CHARACTERIZATION OF THE BINDING OF LOW-DENSITY LIPOPROTEINS TO CULTURED RAT MESANGIAL CELLS [J].
WHEELER, DC ;
FERNANDO, RL ;
GILLETT, MPT ;
ZARUBA, J ;
PERSAUD, J ;
KINGSTONE, D ;
VARGHESE, Z ;
MOORHEAD, JF .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (10) :701-708
[58]   EFFECTS OF LOW-DENSITY LIPOPROTEINS ON MESANGIAL CELL-GROWTH AND VIABILITY INVITRO [J].
WHEELER, DC ;
PERSAUD, JW ;
FERNANDO, R ;
SWENY, P ;
VARGHESE, Z ;
MOORHEAD, JF .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (03) :185-191
[59]   ROLE OF OXIDIZED LOW-DENSITY-LIPOPROTEIN IN ATHEROGENESIS [J].
WITZTUM, JL ;
STEINBERG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1785-1792
[60]   ROLE OF INTRINSIC ANTIOXIDANT ENZYMES IN RENAL OXIDANT INJURY [J].
YOSHIOKA, T ;
BILLS, T ;
MOOREJARRETT, T ;
GREENE, HL ;
BURR, IM ;
ICHIKAWA, I .
KIDNEY INTERNATIONAL, 1990, 38 (02) :282-288